NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

Sub Atomic master,

You bet sorting all this data out is hard and time consuming. They must do it because OS is unlike anything they have ever seen before in GBM. The blinded trial might be having trouble ending early by relying on PFS alone or the trial was unblinded and they are seeking approval so they are waiting on OS events which is complicated from FDA mandated crossover delaying OS events ("..doesn't really help our trial..." Dr. Linda Liau). This will complicate the approval process as per Flipper's comments.